Skip to main content
Past Event

Brookings Roundtable on Active Medical Product Surveillance: Monitoring the Safety of the 2009 H1N1 Influenza Vaccine in Near-Real Time: Learnings from PRISM

Past Event

Monitoring the Safety of the 2009 H1N1 Influenza Vaccine in Near-Real Time: Learnings from PRISM

On October 22, the Engelberg Center for Health Care Reform hosted a roundtable webinar, “Monitoring the Safety of the 2009 H1N1 Influenza Vaccine in Near Real-Time: Learnings from PRISM.”

The roundtable featured presentations from key experts on lessons learned from the implementation of the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) project, a coordinated federal strategy to monitor the safety of the 2009 H1N1 influenza vaccine using observational data from large health plans. Presenters provided an overview of PRISM and project conclusions, and described technical findings related to data infrastructure and methodological approaches.  Discussion also focused on plans to integrate PRISM with the Mini-Sentinel active surveillance system.

Agenda

Welcome and Introduction

Mark B. McClellan

Former Brookings Expert

Mark McClellan is a senior fellow and director of the Health Care Innovation and Value Initiative at Brookings. He has written a number of publications on care delivery reform, physician payment reform, and accountable care implementation in the U.S. and abroad.

HHS Rapid Response to a Public Health Need: H1N1 Vaccine Safety Surveillance

D

Dan Salmon

National Vaccine Program Office, U.S. Department of Health and Human Services

Data Infrastructure and Methodological Lessons Learned from PRISM

R

Richard Platt

Professor and Chair, Department of Population Medicine - Harvard Pilgrim Health Care Institute

Next Steps for Vaccine Safety Surveillance

R

Robert Ball

Deputy Director of the Office of Surveillance and Epidemiology - U.S. Food and Drug Administration

More Information

More

Get a weekly events calendar from Brookings